Author

R. R. Roa

Institution: Mayo Clinic in Florida

Observed institution: Mayo Clinic in Florida

OpenAlex ID: A5126206243

Abstract PS5-01-16: Phase II Trial of the FASN Inhibitor, Denifanstat (TVB-2640), Plus Trastuzumab in Combination with Paclitaxel or Endocrine Therapy (ET) in Patients with HER2+ Metastatic Breast Cancer (MBC) Resistant to Trastuzumab

2026 · T. C. Haddad, V. J. Suman, et al. · Clinical Cancer Research · 2

Works count: 1

Citation count: 2

H-index: 1

I10-index: